Nurix Therapeutics Inc. – Investors and Politicians Who Own It
NRIX
Investors who own it
7 tracked investors, $635.3M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
David KroinDeep Track Capital, Q2 2026 | $187.7M | 2.73% |
David RosenRubric Capital Management, Q2 2026 | $175.3M | 1.61% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $113M | 0.57% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $104.8M | 1.57% |
Cathie WoodARK Investment Management, Q2 2026 | $43.5M | 0.28% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $7.6M | 0.35% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $3.4M | 0.01% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| David Kroin | Added +16% | 7,036,455 |
| Joseph Edelman | Added +151% | 3,555,877 |
| Julian i Felix Baker | Added +20% | 4,658,556 |
| David Rosen | New | 2,473,885 |
| Cathie Wood | Added +6.1% | 1,602,539 |
| Daniel Schneeberger | Added +131% | 72,070 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.